Literature DB >> 27035873

miR-100 suppresses the proliferation and tumor growth of esophageal squamous cancer cells via targeting CXCR7.

Shao-Mei Zhou1, Fang Zhang1, Xue-Bin Chen1, Cao-Ming Jun1, Xin Jing1, Deng-Xiong Wei1, Yang Xia1, Yu-Bai Zhou1, Xiang-Qian Xiao1, Run-Qing Jia1, Jing-Tao Li1, Wang Sheng1, Yi Zeng1.   

Abstract

MicroRNAs are highly conserved non-coding RNAs that regulate gene expression at the post-transcriptional level, and play pivotal roles in cancer development and progression. miR-100 has been reported to be significantly downregulated in a variety of cancers, including esophageal cancer. However, the role of miR-100 in human esophageal cancer has not been fully elucidated. We demonstrated that overexpression of miR-100 in esophageal cancer cells markedly inhibited cell proliferation, migration and invasion as well as tumor growth. We subsequently showed that CXCR7 is a direct target gene of miR-100. Our results indicated that miR-100 plays a tumor-suppressor role in esophageal cancer and suggest its potential application for esophageal cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27035873     DOI: 10.3892/or.2016.4701

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

1.  MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7.

Authors:  Yongfeng Cao; Jiaye Song; Jianjuan Ge; Zhuchen Song; Jia Chen; Changping Wu
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

2.  Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression.

Authors:  Solbi Kim; Ji-Eun Kim; Nayoung Kim; Mina Joo; Myung-Won Lee; Heung Jin Jeon; Hyewon Ryu; Ik-Chan Song; Gyu-Yong Song; Hyo Jin Lee
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

Review 3.  Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer.

Authors:  Xiaobin Hou; Jiaxin Wen; Zhipeng Ren; Guoliang Zhang
Journal:  Oncotarget       Date:  2017-06-27

4.  Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling.

Authors:  Ying Yue; Mengjia Song; Yamin Qiao; Pupu Li; Yiqiang Yuan; Jingyao Lian; Suying Wang; Yi Zhang
Journal:  Oncotarget       Date:  2017-10-30

5.  CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro.

Authors:  Tingting Qian; Yancheng Liu; Yan Dong; Lei Zhang; Yining Dong; Yanhui Sun; Dongmei Sun
Journal:  Mol Med Rep       Date:  2017-12-15       Impact factor: 2.952

6.  Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells.

Authors:  Meng Yang; Chen Zeng; Peiting Li; Liyuan Qian; Boni Ding; Lihua Huang; Gang Li; Han Jiang; Ni Gong; Wei Wu
Journal:  Onco Targets Ther       Date:  2019-05-17       Impact factor: 4.147

Review 7.  Emerging insights into the biology of metastasis: A review article.

Authors:  Soussan Irani
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

8.  The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma.

Authors:  Xue Bai; Zhenzhen Liu; Xiaojian Shao; Di Wang; Encheng Dong; Yan Wang; Chung-I Wu; Yunfei Yuan; Xuemei Lu; Chunyan Li
Journal:  PLoS One       Date:  2019-02-05       Impact factor: 3.240

9.  Systematic Analysis of Transcriptomic Profile of Renal Cell Carcinoma under Long-Term Hypoxia Using Next-Generation Sequencing and Bioinformatics.

Authors:  Szu-Chia Chen; Feng-Wei Chen; Ya-Ling Hsu; Po-Lin Kuo
Journal:  Int J Mol Sci       Date:  2017-12-07       Impact factor: 5.923

10.  High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids.

Authors:  Ida Rapa; Arianna Votta; Gaia Gatti; Stefania Izzo; Nicola Lo Buono; Elisa Giorgio; Simona Vatrano; Francesca Napoli; Aldo Scarpa; Giorgio Scagliotti; Mauro Papotti; Marco Volante
Journal:  Oncotarget       Date:  2018-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.